Guideline-recommended OTC carpal tunnel management with first-line treatments like activity modification and neutral-position wrist splints, particularly at night, to reduce nerve compression. Avoid ineffective therapies such as oral medications or magnet therapy. For persistent symptoms, professional interventions like corticosteroid injections, physical therapy, or, in severe cases, carpal tunnel release surgery may be necessary.
January 8, 2025

Carpal Tunnel Syndrome: Get Better With At-Home Conservative Treatment

Evidence-Based Over-The-Counter Guide

William Shen

William Shen

Co-founder & CPO

See all guides. Have more questions?

Carpal Tunnel Syndrome is a condition caused by compression of the median nerve within the carpal tunnel of the wrist, leading to symptoms such as pain, tingling, and numbness in the hand.

First-line recommendations:

  • Activity modification: Avoid repetitive wrist movements or prolonged gripping activities.

  • Wrist splints: Use a neutral-position wrist splint, especially at night, to relieve nerve compression. Adjustable night-time wrist brace.

Not recommended:

  • Oral medications: Moderate evidence supports no benefit of oral treatments (diuretic, gabapentin, astaxanthin capsules, NSAIDs, or pyridoxine) compared to placebo.

  • Magnet therapy: Strong evidence supports not using magnet therapy for the treatment of CTS.

Professional intervention:

  • Corticosteroid injections: Intracarpal injection of methylprednisolone or triamcinolone can reduce inflammation and provide symptom relief.

  • Oral steroids: Should only be used short-term (e.g., 2–4 weeks); monitor for side effects of glucocorticoid therapy

  • Physical therapy: Prescribed for nerve gliding and strengthening exercises.

  • Surgical intervention: For severe or refractory cases, carpal tunnel release surgery may be recommended to decompress the nerve

Citation

Graham et al. Management of Carpal Tunnel Syndrome Evidence-Based Clinical Practice Guideline. J Bone Joint Surg Am. 2016; 98(20): p.1750-1754. doi: 10.2106/JBJS.16.00719

What OTC evidence is reviewed?

  • For each condition, we performed a literature review to find a recent widely cited expert group guideline published in the leading specialty-specific peer-reviewed journal or top general medical journal.

  • Based on the recommendations in the publication, we identify recommended active ingredients and devices that are available over-the-counter per FDA regulations.

What evidence is prioritized?

Levels of evidence considered:

  • Tier 1 (Safe and Definitely Effective): Professional field consensus or multiple randomized controlled clinical trials showing the same conclusion. Wherever possible, we use Tier 1 evidence for "first-line" recommendations.

  • Tier 2 (Safe and Probably Effective): Individual clinical trials which may be discordant or large-scale observational experience. Tier 2 evidence may inform "first-line", "second-line", or "supplement" recommendations.

  • Tier 3 (Safe and Maybe Effective): Mechanistic plausibility without high-quality clinical evidence of efficacy but high-quality evidence of safety. Tier 3 evidence may inform "second-line" or "supplement" recommendations.

How does MDandMe select recommended products?

  • Based on the top clinical recommendation, we evaluate products containing the recommended active agent with FDA-approved dosage based on price, average customer reviews, how often it is purchased, and how quickly it will ship to home. 

  • We provide public documentation of the active ingredients in our recommendations, using all 32 FDA monographs, Prescription-to-Nonprescription (Rx-to-OTC) Switches, as well as New Drug Application (NDA) approvals.

How does MDandMe select recommended devices?

  • Based on the top clinical recommendation, we evaluate devices that are FDA-cleared or comply with other medical guidelines (if not a FDA-regulated category) by reputability, price, and average customer reviews.

  • We provide public documentation of supporting evidence for each device.